Lunt SJ - Search Results

1

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Silk JD, et al. Among authors: lunt sj. J Clin Invest. 2004 Dec;114(12):1800-11. doi: 10.1172/JCI22046. J Clin Invest. 2004. PMID: 15599405 Free PMC article.

2

Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination.

Lunt SJ, Telfer BA, Fitzmaurice RJ, Stratford IJ, Williams KJ. Lunt SJ, et al. Clin Cancer Res. 2005 Jun 1;11(11):4212-6. doi: 10.1158/1078-0432.CCR-04-2162. Clin Cancer Res. 2005. PMID: 15930359 Free article.

3

The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

Lunt SJ, Cawthorne C, Ali M, Telfer BA, Babur M, Smigova A, Julyan PJ, Price PM, Stratford IJ, Bloomer WD, Papadopoulou MV, Williams KJ. Lunt SJ, et al. Br J Cancer. 2010 Jul 13;103(2):201-8. doi: 10.1038/sj.bjc.6605753. Epub 2010 Jun 29. Br J Cancer. 2010. PMID: 20588272 Free PMC article.

4

Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.

Lunt SJ, Akerman S, Hill SA, Fisher M, Wright VJ, Reyes-Aldasoro CC, Tozer GM, Kanthou C. Lunt SJ, et al. Int J Cancer. 2011 Oct 15;129(8):1979-89. doi: 10.1002/ijc.25848. Epub 2011 Apr 13. Int J Cancer. 2011. PMID: 21154772 Free article.

5

Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in Sarcoma.

English WR, Lunt SJ, Fisher M, Lefley DV, Dhingra M, Lee YC, Bingham K, Hurrell JE, Lyons SK, Kanthou C, Tozer GM. English WR, et al. Among authors: lunt sj. Cancer Res. 2017 May 15;77(10):2633-2646. doi: 10.1158/0008-5472.CAN-16-0255. Epub 2017 Apr 4. Cancer Res. 2017. PMID: 28377452 Free article.

6

Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors.

Skliarenko JV, Lunt SJ, Gordon ML, Vitkin A, Milosevic M, Hill RP. Skliarenko JV, et al. Among authors: lunt sj. Cancer Res. 2006 Feb 15;66(4):2074-80. doi: 10.1158/0008-5472.CAN-05-2046. Cancer Res. 2006. PMID: 16489007

7

Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategies.

Akerman S, Fisher M, Daniel RA, Lefley D, Reyes-Aldasoro CC, Lunt SJ, Harris S, Bjorndahl M, Williams LJ, Evans H, Barber PR, Prise VE, Vojnovic B, Kanthou C, Tozer GM. Akerman S, et al. Among authors: lunt sj. Int J Cancer. 2013 Dec 1;133(11):2563-76. doi: 10.1002/ijc.28281. Epub 2013 Jul 10. Int J Cancer. 2013. PMID: 23712501 Free article.

8

Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours.

Lunt SJ, Kalliomaki TM, Brown A, Yang VX, Milosevic M, Hill RP. Lunt SJ, et al. BMC Cancer. 2008 Jan 7;8:2. doi: 10.1186/1471-2407-8-2. BMC Cancer. 2008. PMID: 18179711 Free PMC article.

9

Application of intravital microscopy in studies of tumor microcirculation.

Lunt SJ, Gray C, Reyes-Aldasoro CC, Matcher SJ, Tozer GM. Lunt SJ, et al. J Biomed Opt. 2010 Jan-Feb;15(1):011113. doi: 10.1117/1.3281674. J Biomed Opt. 2010. PMID: 20210439 Free article. Review.

10

The tumor microenvironment and metastatic disease.

Lunt SJ, Chaudary N, Hill RP. Lunt SJ, et al. Clin Exp Metastasis. 2009;26(1):19-34. doi: 10.1007/s10585-008-9182-2. Epub 2008 Jun 10. Clin Exp Metastasis. 2009. PMID: 18543068 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page